non-financial development institution
major organizer of congress and exhibition events
Welcome!
Восстановление пароля
Введите адрес электронной почты или телефон, указанные при регистрации. Вам будет отправлена инструкция по восстановлению пароля.
Некорректный формат электронной почты или телефона
Краевой Сергей

Sergei Kraevoi

Deputy Minister of Healthcare of the Russian Federation
Quotes
13.02.2019
Healthy Life Forum: Towards 80+ 2019
Infectious Diseases: How to Meet the UN Sustainable Development Goals by 2030?
The most important thing is training professionals. Because we may have good intentions, we may have unlimited funding – or so I hope – but if we don’t have well-trained staff, we won’t be able to accomplish anything
13.02.2019
Healthy Life Forum: Towards 80+ 2019
Infectious Diseases: How to Meet the UN Sustainable Development Goals by 2030?
Further improvements of diagnosis are required. An accurate and timely diagnosis, accurate identification of pathogen susceptibility allows us to prescribe adequate specific treatment, thus achieving the key objective
26.05.2018
SPIEF 2018
Regulating the Technological Singularity: How Can We Open Doors to the New?
Singularity will never be achieved. And science fiction writers specifically warned us: "Know about this, prepare for it, but you will never live to that day." When there something new appears, it gets regulated. And that's why we will never live to the day with no rules or laws
26.05.2018
SPIEF 2018
Life Sciences in 2030: A New Era for Biotechnology
Gene and cell therapy, new recombinant drugs and the new materials needed to make up for lost functions are among the main trends today. <...> We are working intensively on the regulatory basis for medication approval and registration of medical devices. We already can state that our regulatory framework is one of the most loyal to both developers and producers
26.05.2018
SPIEF 2018
Life Sciences in 2030: A New Era for Biotechnology
Together with HealthNet, we are working on the issue of identifying special innovative medicines and medical products. We are working to legalize the use of laboratories for advanced development. We want to identify when it is allowed to use diagnostic and treatment methods that have not yet been registered, yet the developer still submits them with the expert community approval. This is the methodology of directed innovative development